These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2553737)

  • 1. Adenylate cyclase toxin from Bordetella pertussis. Identification and purification of the holotoxin molecule.
    Hewlett EL; Gordon VM; McCaffery JD; Sutherland WM; Gray MC
    J Biol Chem; 1989 Nov; 264(32):19379-84. PubMed ID: 2553737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography.
    Friedman RL
    Infect Immun; 1987 Jan; 55(1):129-34. PubMed ID: 2878883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive adenylate cyclase toxin of Bordetella pertussis.
    Hanski E
    Trends Biochem Sci; 1989 Nov; 14(11):459-63. PubMed ID: 2560273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.
    Hewlett EL; Gray MC; Ehrmann IE; Maloney NJ; Otero AS; Gray L; Allietta M; Szabo G; Weiss AA; Barry EM
    J Biol Chem; 1993 Apr; 268(11):7842-8. PubMed ID: 8385122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis.
    Rogel A; Meller R; Hanski E
    J Biol Chem; 1991 Feb; 266(5):3154-61. PubMed ID: 1847141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme.
    Rogel A; Schultz JE; Brownlie RM; Coote JG; Parton R; Hanski E
    EMBO J; 1989 Sep; 8(9):2755-60. PubMed ID: 2555185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of Ca2+ with the calmodulin-sensitive adenylate cyclase from Bordetella pertussis.
    Masure HR; Oldenburg DJ; Donovan MG; Shattuck RL; Storm DR
    J Biol Chem; 1988 May; 263(14):6933-40. PubMed ID: 2896201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a calmodulin-sensitive adenylate cyclase from Bordetella pertussis.
    Shattuck RL; Oldenburg DJ; Storm DR
    Biochemistry; 1985 Nov; 24(23):6356-62. PubMed ID: 2867778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase.
    Murayama T; Hewlett EL; Maloney NJ; Justice JM; Moss J
    Biochemistry; 1994 Dec; 33(51):15293-7. PubMed ID: 7803392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis.
    Ehrmann IE; Gray MC; Gordon VM; Gray LS; Hewlett EL
    FEBS Lett; 1991 Jan; 278(1):79-83. PubMed ID: 1993477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and assay of cell-invasive form of calmodulin-sensitive adenylyl cyclase from Bordetella pertussis.
    Masure HR; Donovan MG; Storm DR
    Methods Enzymol; 1991; 195():137-52. PubMed ID: 1851926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
    Lee SJ; Gray MC; Guo L; Sebo P; Hewlett EL
    Infect Immun; 1999 May; 67(5):2090-5. PubMed ID: 10225859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic activity of adenylate cyclase toxin from Bordetella pertussis is not required for hemolysis.
    Ehrmann IE; Weiss AA; Goodwin MS; Gray MC; Barry E; Hewlett EL
    FEBS Lett; 1992 Jun; 304(1):51-6. PubMed ID: 1319923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.
    Friedman RL; Fiederlein RL; Glasser L; Galgiani JN
    Infect Immun; 1987 Jan; 55(1):135-40. PubMed ID: 2878884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities.
    Sakamoto H; Bellalou J; Sebo P; Ladant D
    J Biol Chem; 1992 Jul; 267(19):13598-602. PubMed ID: 1618862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay.
    Ladant D; Brezin C; Alonso JM; Crenon I; Guiso N
    J Biol Chem; 1986 Dec; 261(34):16264-9. PubMed ID: 2877986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive adenylyl cyclase of Bordetella pertussis. Physical, catalytic, and toxic properties.
    Gentile F; Knipling LG; Sackett DL; Wolff J
    J Biol Chem; 1990 Jun; 265(18):10686-92. PubMed ID: 1693922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordatella pertussis adenylate cyclase: a toxin with multiple talents.
    Ladant D; Ullmann A
    Trends Microbiol; 1999 Apr; 7(4):172-6. PubMed ID: 10217833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin.
    Gordon VM; Leppla SH; Hewlett EL
    Infect Immun; 1988 May; 56(5):1066-9. PubMed ID: 2895741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin.
    Iwaki M; Kamachi K; Heveker N; Konda T
    Infect Immun; 1999 Jun; 67(6):2763-8. PubMed ID: 10338478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.